Jacobio Pharmaceuticals Group Co (HKSE:01167) YoY EBITDA Growth : 109.89% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Jacobio Pharmaceuticals Group Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 109.89%.

Jacobio Pharmaceuticals Group Co's EBITDA per Share for the six months ended in Dec. 2024 was HK$0.03.

Jacobio Pharmaceuticals Group Co YoY EBITDA Growth Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co YoY EBITDA Growth Chart

Jacobio Pharmaceuticals Group Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-677.41

89.85

-11.16

12.69

63.77

Jacobio Pharmaceuticals Group Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial								-33.46	-15.66	26.74	2.18	109.89

Jacobio Pharmaceuticals Group Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Jacobio Pharmaceuticals Group Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.167	-	-0.461)	/	\| -0.461 \|
=	63.77 %

Jacobio Pharmaceuticals Group Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(0.026	-	-0.263)	/	\| -0.263 \|
=	109.89 %

Jacobio Pharmaceuticals Group Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobio Pharmaceuticals Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

77V:Germany

Address

No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN

Website

https://www.jacobiopharma.com

Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Executives

Yakovpharma Ltd	2501 Other
Blesspharma Ltd	2501 Other
Honourpharma Ltd	2501 Other
Gloryviewpharma Ltd	2501 Other
Hmed Ltd	2501 Other
Johwpharma Ltd	2501 Other
Risepharma Ltd	2101 Beneficial owner
Willgenpharma Ltd	2501 Other
Hu Yunyan	2501 Other
Wang Xiaojie	2307 Founder of a discretionary trust who can infl
Wang Yinxiang	2501 Other
Qiming Corporate Gp Vi, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp Vi, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners Vi, L.p.	2101 Beneficial owner
Hillhouse Investment Management, Ltd.	2102 Investment manager

Jacobio Pharmaceuticals Group Co Headlines

No Headlines